VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 128 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 7.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $36,582,000 | +6.3% | 1,400,000 | -6.7% | 0.10% | +31.2% |
| Q3 2018 | $34,425,000 | +29.1% | 1,500,000 | +7.1% | 0.08% | +26.2% |
| Q2 2018 | $26,670,000 | +13.1% | 1,400,000 | 0.0% | 0.06% | +10.9% |
| Q1 2018 | $23,590,000 | +697.8% | 1,400,000 | +619.6% | 0.06% | +685.7% |
| Q4 2017 | $2,957,000 | -65.0% | 194,541 | -74.1% | 0.01% | -69.6% |
| Q3 2015 | $8,460,000 | +40.3% | 750,000 | +57.9% | 0.02% | +53.3% |
| Q2 2015 | $6,028,000 | +85.2% | 475,000 | +35.7% | 0.02% | +87.5% |
| Q1 2015 | $3,255,000 | -39.4% | 350,000 | -6.7% | 0.01% | -38.5% |
| Q4 2014 | $5,370,000 | – | 375,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |